Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

GAO: Prior Authorization For Medicare Imaging Scans Should Be On The Table

This article was originally published in The Pink Sheet Daily

Executive Summary

Preapproval won’t work for CMS the way it does in the private sector, and other curbs are in place, stakeholders retort.

You may also be interested in...



CMS Urged To Cover Beta Amyloid PET Scans For Alzheimer's, But Cautiously

Imaging stakeholders call for Medicare coverage of beta amyloid positron emission tomography scans to help diagnose and manage dementia patients, but clinical societies warn against using the technology as a screening tool for Alzheimer’s disease. CMS took comments through Nov. 8 on its ongoing national coverage analysis.

French Firm Explores U.S. Regulatory Strategy For Blood-based Alzheimer’s Test

With a CE mark in hand, Exonhit is training its sights on the U.S. market. A 160-patient pilot study conducted through the Cleveland Clinic completed enrollment a few weeks ago.

Clarity Over Health Care Reform Boosts Telehealth Prospects

Accountable care organizations and the Center for Medicare and Medicaid Innovation are driving growth in telemedicine.

Topics

UsernamePublicRestriction

Register

ID1128360

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel